The Role of Mitochondria in Ischemic Heart Disease
- 1 January 1996
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 28, 1-10
- https://doi.org/10.1097/00005344-199600003-00002
Abstract
Mitochondria in the heart play two roles essential for cell survival: ATP synthesis and maintenance of Ca2+ homeostasis. These two processes are driven by the same energy source, the H+ electrochemical gradient (delta microH). Under aerobic physiologic conditions, mitochondria do not contribute to the beat-to-beat regulation of cytosolic Ca2+, although a Ca2+ transient in mitochondrial matrix has been described. Micromolar increases in mitochondrial Ca2+ concentration stimulate the Krebs cycle and the NADH redox potential and, therefore, ATP synthesis. Trimetazidine has been shown to improve the calcium transient and, in so doing, the overall myocardial energy production. Under pathologic conditions, mitochondrial Ca2+ overload causes a series of vicious cycles that lead to irreversible cell damage. During ischemia, an alteration in intracellular Ca2+ homeostasis occurs and mitochondria are able to buffer cytosolic Ca2+, suggesting that they retain the Ca(2+)-transporting capacity. Accordingly, once isolated, even after prolonged ischemia the majority of the mitochondria are able to use oxygen for ATP phosphorylation. When isolated after reperfusion, mitochondria are structurally altered, contain large quantities of Ca2+, and produce an excess of oxygen free radicals. Their membrane pores are stimulated and the capacity for oxidative phosphorylation is irreversibly disrupted. The role of mitochondrial DNA damage in progressive human diseases such as coronary atherosclerosis is receiving growing interest. The sequence of ischemia and reperfusion, through increased production of oxygen free radicals, causes mitochondrial deletions in several areas of the mitochondrial genome. This cumulative mitochondrial DNA damage is associated with induction of nuclear oxidative phosphorylation gene mRNA. These observations support the hypothesis that mitochondria and mitochondrial DNA damage play important roles in ischemic heart disease.Keywords
This publication has 66 references indexed in Scilit:
- Age-dependent increase in deleted mitochondrial DNA in the human heart: Possible contributory factor to presbycardiaAmerican Heart Journal, 1991
- Protective Effects of Calcium Antagonists Against Ischaemia and Reperfusion DamageDrugs, 1991
- Multiple mitochondrial DNA deletions exist in cardiomyocytes of patients with hypertrophic or dilated cardiomyopathyBiochemical and Biophysical Research Communications, 1990
- Cardiomyopathy of OverloadNew England Journal of Medicine, 1990
- Effect of D-600 on ischemic and reperfused rabbit myocardium: relation with timing and modality of administrationBasic Research in Cardiology, 1989
- Mitochondrial DNA Mutation Associated with Leber's Hereditary Optic NeuropathyScience, 1988
- Cardiac Muscle Changes in SenescenceAnnual Review of Physiology, 1987
- Allosteric inhibition of the Ca2+-activated hydrophilic channel of the mitochondrial inner membrane by nucleotidesThe Journal of Membrane Biology, 1980
- Fate during cell growth of yeast mitochondrial and nuclear DNA after photolytic attachment of the monoazide analog of ethidiumBiochemical and Biophysical Research Communications, 1979
- Involvement of endogenous phospholipase A2 in Ca2+ and Mg2+ movements induced by inorganic phosphate and diamide in rat liver mitochondriaBiochemical and Biophysical Research Communications, 1979